These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 24038809)

  • 41. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
    Zhang F; Huang W; Sheng M; Liu T
    Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
    Wang T; Ji F; Dai Z; Xie Y; Yuan D
    Cancer Biomark; 2015; 15(5):543-50. PubMed ID: 26406942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival.
    Folio C; Zalacain M; Zandueta C; Ormazábal C; Sierrasesúmaga L; San Julián M; de las Rivas J; Toledo G; Lecanda F; Patiño-García A
    Cancer Biomark; 2011-2012; 10(1):35-41. PubMed ID: 22297550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
    Sun B; Yang M; Li M; Wang F
    Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
    Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
    Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma.
    Taheriazam A; Talaei AJ; Jamshidi M; Shakeri M; Khoshbakht S; Yahaghi E; Shokrani M
    Diagn Pathol; 2015 Oct; 10():184. PubMed ID: 26446495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
    Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
    Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
    Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
    Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
    Yuan J; Chen L; Chen X; Sun W; Zhou X
    J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma.
    Xia H; Yamada S; Aoyama M; Sato F; Masaki A; Ge Y; Ri M; Ishida T; Ueda R; Utsunomiya A; Asai K; Inagaki H
    Hum Pathol; 2014 Jun; 45(6):1192-8. PubMed ID: 24745613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
    Cheng DD; Yu T; Hu T; Yao M; Fan CY; Yang QC
    Oncotarget; 2015 Dec; 6(40):42761-72. PubMed ID: 26498360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.